Veru Inc (NASDAQ:VERU) — Market Cap & Net Worth
Market Cap & Net Worth: Veru Inc (VERU)
Veru Inc (NASDAQ:VERU) has a market capitalization of $36.76 Million ($36.76 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23106 globally and #4982 in its home market, demonstrating a -3.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Veru Inc's stock price $2.99 by its total outstanding shares 16050320 (16.05 Million). Review Veru Inc (VERU) total liabilities to assess the company's total debt and financial obligations.
Veru Inc Market Cap History: 2015 to 2026
Veru Inc's market capitalization history from 2015 to 2026. Data shows growth from $23.27 Million to $47.99 Million (4.09% CAGR).
Index Memberships
Veru Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2200 of 3165 |
Weight: Veru Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Veru Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Veru Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.62x
Veru Inc's market cap is 0.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $14.61 Million | $22.13 Million | $344.73K | 0.66x | 42.37x |
| 2017 | $18.30 Million | $13.66 Million | -$6.61 Million | 1.34x | N/A |
| 2018 | $22.47 Million | $15.86 Million | -$23.94 Million | 1.42x | N/A |
| 2019 | $53.77 Million | $31.80 Million | -$12.02 Million | 1.69x | N/A |
| 2020 | $138.84 Million | $42.59 Million | -$18.97 Million | 3.26x | N/A |
| 2021 | $94.54 Million | $61.26 Million | $7.39 Million | 1.54x | 12.78x |
| 2022 | $84.75 Million | $39.35 Million | -$83.78 Million | 2.15x | N/A |
| 2023 | $11.56 Million | $16.30 Million | -$93.15 Million | 0.71x | N/A |
| 2024 | $10.44 Million | $16.89 Million | -$37.80 Million | 0.62x | N/A |
Competitor Companies of VERU by Market Capitalization
Companies near Veru Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Veru Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
- UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $458.99 |
| #444 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.63 Billion | $607.93 |
| #549 | UCB SA | BR:UCB | $49.68 Billion | €252.40 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €780.20 |
Veru Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Veru Inc's market cap moved from $23.27 Million to $ 47.99 Million, with a yearly change of 4.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $47.99 Million | +39.72% |
| 2025 | $34.35 Million | +228.98% |
| 2024 | $10.44 Million | -9.65% |
| 2023 | $11.56 Million | -86.36% |
| 2022 | $84.75 Million | -10.36% |
| 2021 | $94.54 Million | -31.91% |
| 2020 | $138.84 Million | +158.21% |
| 2019 | $53.77 Million | +139.29% |
| 2018 | $22.47 Million | +22.81% |
| 2017 | $18.30 Million | +25.27% |
| 2016 | $14.61 Million | -37.24% |
| 2015 | $23.27 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Veru Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.76 Million USD |
| MoneyControl | $36.76 Million USD |
| MarketWatch | $36.76 Million USD |
| marketcap.company | $36.76 Million USD |
| Reuters | $36.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Veru Inc
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosa… Read more